Navigation Links
CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
Date:11/6/2009

ational treatment."

The initiation of CEL-SCI's rapidly-accelerated LEAPS-H1N1 clinical development program builds on CEL-SCI's pioneering work with its LEAPS technology in the context of H1N1. CEL-SCI's L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) technology allows the Company to direct an immune response against specific disease epitopes. In the case of CEL-SCI's investigational LEAPS-H1N1 treatment, this involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu. This is intended to enable stimulation of the specifically-needed immune responses, while avoiding the administration of regions of H1N1, and other viruses, which may exacerbate the problem of cytokine storm, which CEL-SCI scientists believe may be involved in the death of some H1N1 patients.

L.E.A.P.S. technology is a novel T-cell modulation platform technology that enables CEL-SCI to design and synthesize, non-recombinantly, proprietary immunogens. The L.E.A.P.S. technology combines a small peptide that activates the immune system with a small peptide from a disease-related protein, such as the H1N1 hemagglutinin molecule, to make an investigational product that induces defined immune responses. Each L.E.A.P.S. construct is composed of a T cell binding ligand (TCBL) which previously has demonstrated the ability to induce and elicit protective immunity and antigen-specific antibody production in animal models. Thus, extensive animal studies conducted to date indicate that any disease for which an antigenic sequence has been identified, such as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or preventive sites for the application of L.E.A.P.S. technology.

About CEL-SCI Corporation

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine® which is being readied for a global Phase III trial in advanced primary he
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
2. CEL-SCI Corporation to Raise $20 Million in Registered Direct Offering
3. CEL-SCI Corporation Announces Elimination of $8.3 Million Convertible Notes
4. CEL-SCI Completes $5.85 Million Registered Direct Offering
5. CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
6. CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
7. CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
8. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
9. CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
10. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
11. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Myers, FL (PRWEB) July 25, 2014 ... iPhones, iPods, and iPads. The app provides a tailored ... painful and potentially dangerous sunburns and skin damage. In ... the sights, sounds, and capabilities of iTanSmart. , ... describing the app as a ‘better organized’ and ‘great ...
(Date:7/25/2014)... As the category creator and world leader in healthy ... transform and improve individual lives worldwide through its exclusive and ... a successful Austin, Texas based "Xocai Activ Drink" author, is ... July to promote the up and coming mxicorp.com/company/igc Eric Worre ... has been a leader in the Network Marketing Profession for ...
(Date:7/24/2014)... July 25, 2014 iFitDress.com, a renowned ... new range of casual party dresses . According ... party gowns are now offered at discounted prices, up ... this morning until August 04. , Most of ... in the global market. They are popular for special ...
(Date:7/24/2014)... For rats bearing human breast tumors, exposure to dim ... breast cancer drug tamoxifen, according to data published in ... Association for Cancer Research. The negative effects of dim ... rats a melatonin supplement during the night. , "Resistance ... hormone receptor-positive breast cancer," said Steven M. Hill, PhD, ...
(Date:7/24/2014)... Ticket Down is a reliable source for cheap Manchester ... Authority Field on July 26th. For the past four years, the ... the best club teams from around the world to North America ... weeks after its completion, fans – new and old alike – ... in the world compete. Some of these players were already members ...
Breaking Medicine News(10 mins):Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 3
... , CAMPBELL, Calif., Dec. 1 Last month on a prominent ... Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended ... sleep plan for people trying to achieve a better night,s sleep ... for people when they are sleeping," said Dr. Pelayo. "There are ...
... Results of a large-scale clinical trial presented today at ... (RSNA) provide the first strong evidence of the benefit of ... at elevated risk for breast cancer. In addition, the study ... cancer. , "We found that annual screening with ultrasound in ...
... , , CHICAGO, Dec. 2 Targeted ... is a safe, reliable and cost-effective alternative to invasive biopsies ... two studies presented today at the annual meeting of the ... breast ultrasound, we can reduce the number of expensive and ...
... , SEATTLE, Dec. 2 ... today that Ruth Pettengell, M.D. of St. George,s Hospital, University ... trial will present new data on the pixantrone phase III ... Annual Meeting of the American Society of Hematology on Saturday, ...
... standard conservative therapy to a minimally invasive treatment called ... while both treatments help patients in the short run, ... two years later. Results of the study, the first ... meeting of the Radiological Society of North America (RSNA). ...
... ... , ... (Vocus) -- Omnetics Connector Corporation, the world leader in nano-miniature connectors, has announced the ... These are the smallest Mil-Quality circulars available. The threaded metal shell provides a ...
Cached Medicine News:Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Omnetics Announces Newest Addition to Nano Circular Family 2
(Date:7/24/2014)... July 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), ... company, announced its financial results for the second quarter ended ... , Total revenues of $6.5 million in the second ... quarter in 2013 , Total revenues of $13.3 million ... of 78% over the same period in 2013 , ...
(Date:7/24/2014)... ANGELES , July 24, 2014 Many new ... they can do to ensure that their practice will be ... purchase the basic supplies they use the most can make ... and many dentists have recently discovered that purchasing discount ... loss. According to successful dentists across ...
(Date:7/24/2014)... N.C. , July 24, 2014 ... has signed an Agreement with Kineticos, a ... consulting company. Kineticos will support LSI Medience in ... sepsis management, to demonstrate utility in clinical trials. ... shown potential utility in diagnosis of sepsis, prognosis ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2
... 28, 2011  A 67-year-old man with Alzheimer,s disease is ... outside in near-freezing temperatures thanks to the quick action of ... wearable locator device. Robert Campbell was recovered ... He was located on Victory Boulevard, more than a mile ...
... LOS ANGELES, Feb. 28, 2011 InstaCare Corp. (OTC ... provider of direct to patient diabetes programs, a leading ... chronically ill, and a leading developer of revolutionary cell ... on Thursday, February 24, 2011, the Company filed a ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 2InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 3
Provides 30% more illumination, high light output for true tissue. Wide-angle viewing lens, sealed system for pneumatic otoscopy....
... The Shandon Cryotome FE and FSE are ... Thermo Electron. The microtome is outside of ... cleaning, as well as faster temperature adjustment. ... operation. Complete temperature controls on the main ...
A standard, durable and reliable indirect....
Designed to retain the desired curve during oral intubation....
Medicine Products: